Nordic Nanovector
Committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.
Launch date
Employees
Market cap
CAD48.3m
Enterprise valuation
CAD35m (Public information from Jun 2023)
Share price
NOK1.01 NANOV.F
Oslo Norway (HQ)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | - | <1m | 1.0m | <1m | - | 11.8m |
| % growth | (40 %) | - | - | 11 % | (40 %) | - | - |
| EBITDA | (20.0m) | (34.7m) | (30.0m) | (40.0m) | (40.0m) | - | (<1m) |
| % EBITDA margin | (66667 %) | - | (3333 %) | (4000 %) | (6667 %) | - | (6 %) |
| Profit | 20.0m | (32.3m) | 20.0m | 30.0m | 30.0m | (34.2m) | (2.9m) |
| % profit margin | 66667 % | - | 2222 % | 3000 % | 5000 % | - | (25 %) |
| EV / revenue | - | - | - | - | - | - | 2.4x |
| EV / EBITDA | - | - | - | - | - | - | -38.0x |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
| N/A | N/A | IPO | |
N/A | Grant | ||
$1.3m | Grant | ||
| N/A | $42.5m | Private Placement VC | |
* | N/A | NOK250m | Private Placement VC |
| Total Funding | CAD101m | ||
Related Content
Recent News about Nordic Nanovector
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Nordic Nanovector
Edit
ACQUISITION by Nordic Nanovector Jun 2023